PER Postgame™: Protecting Patients with MS from COVID-19—Exploring the Latest in Prevention and Immunosuppressive Treatment Strategies

PER® Postgame: Breaking Down the Latest Data and Updates in Anemia of Chronic Kidney Disease – Fall 2021 Nephrology Meeting Takeaways

BURST CME™: Deciphering Clinical Trial Endpoints Amidst an Advent of Novel Therapies for Low- to High-Risk MDS

Advances In™ Marginal Zone Lymphoma: Applying New Developments to Practice

Arun Srivastava, PhD; Hanny Al-Samkari, MD

Advances in™ Beta-Thalassemia: The Evolving Therapeutic Landscape

Kelley Robert Branch, MD, MS; Sonia Anand, MD, PhD; Schuyler Jones, MD; Christian Thomas Ruff, MD, MPH

Community Practice Connections: Making the Most of Effective Antithrombotic Strategies in Patients with CAD and PAD

Sagar Lonial, MD, FACP; Meletios A. Dimopoulos, MD

Advances in™: Application of Proteasome Inhibitor Therapies Across the MM Disease Spectrum

Krishna Komanduri, MD; Juan Felipe Ramirez, APRN-BC

Show Me Your Care Plan! Managing Adverse Events Associated with CAR T-Cell Therapies for Oncology Nurses

Oncology Consultations®: Critical Conversations for Treating sAML in the Outpatient Setting

PER® Postgame™: Reporting the Latest Global Updates Across the Treatment of Breast Cancer

Proteolysis-Targeting Chimera (PROTAC) Therapy for Cancer

Kristin Highland, MD, MSCR; Deborah Jo Levine MD FCCP

Expert Illustrations and Commentaries: Finding the Best Path Forward in PAH Management - A Focus on Prostacyclin Therapy

Andre H. Goy, MD; Roy S. Herbst, MD, PhD; Claudine Isaacs, MD; Benjamin P. Levy, MD; John L. Marshall, MD; Eileen M. OReilly, MD

3rd Annual Precision Medicine Symposium: An Illustrated Tumor Board

Oncology Best Practice™ Series: Key Questions for the Community on the Detection and Treatment of MRD

Burst Expert Illustrations & Commentaries™: The Impact of Targeted IL-17 Inhibition on the Treatment for Moderate to Severe Plaque Psoriasis

Dawn Laney, MS, CGC, CCRC: Manesh R. Patel, MD

BURST Clinical Consultations: Addressing Long-term Cardiac and Renal Outcomes in Fabry Disease

David I Quinn, MD, MBBS, PhD, FRACP, FACP

Advances In™: Testing and Treatment of Metastatic CRPC with PARP Inhibitors

Advances In™ Hematology: New Therapeutic Options to Treat AL Amyloidosis

Clinical Vignette Series: How Can We Be More Strategic in Treatment Planning for Patients with ALL?

3rd Annual International Congress on the Future of Neurology®

Anthony Mato, MD, MSCE; Nitin Jain, MD; William G. Wierda, MD, PhD

Community Practice Connections™: How Are We Meeting the Needs of Patients With CLL Across Lines of Care?

Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors

Neal Shore, MD, FACS; Robert Dreicer, MD, MS, MACP, FASCO; Celestia S. Higano, MD, FACP; Daniel P. Petrylak, MD

Community Practice Connections™: How the Experts Approach Testing and Treatment When Utilizing PARP Inhibitors for mCRPC

Community Practice Connections™: Navigating the Latest Evidence to Optimize Utilization of Novel Therapies in R/R CML

Clinical Vignette: Managing Multiple Myeloma From Newly Diagnosed to Relapsed/Refractory Settings: An Expert Case-Based Discussion

Joseph Tauber, MD; John Sheppard, MD, MMSc, FACS

Advances in™ Dry Eye Disease - The Future of Treatment for Patients with Meibomian Gland Dysfunction-Associated DED

Optimizing Use of T-Cell–Engaging Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia

Tanios Bekaii-Saab, MD, FACP; Kristen Ciombor, MD, MSCI; Rachna Shroff, MD, MSEileen M. OReilly, MD;

Community Practice Connections™: 18th Annual Meeting of the International Society of Gastrointestinal Oncology®

Scott Urquhart, PA-C, DFAAPA; Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Brian Bizik, MS PA-C; Margaret Fitzgerald, DNP, FNP-BC,  NP-C, FAANP, CSP, FAAN, DCC,  FNAP; Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA; Leah Smith, MSN, APRN, FNP-BC, CNN- NP, FNKF

4th Annual Advanced Practice Collaborative (APC)

Francis S. Mah, MD; Karolinne Rocha, MD, PhD

(COPE Credit) Patient, Provider, and Caregiver Connection™: Limiting the Patient Burden of Neurotrophic Keratitis

(CME/CNE Credit) Patient, Provider, and Caregiver Connection™: Limiting the Patient Burden of Neurotrophic Keratitis

Advances in™ ALK+ NSCLC: Leveraging Evidence and Patient Characteristics to Inform Treatment

Timothy Craig, DO; Igor Barjaktarevic, MD, PhD

Community Practice Connections™: Alpha-1 Antitrypsin Deficiency—Strategies to Optimize Screening, Diagnosis, and Management

Catherine S. M. Diefenbach, MD; Gilles Salles, MD, PhD

Advances In™ Follicular Lymphoma: Highlighting the Latest Practice Changing-Evidence in Treatment

Oncology Briefings™: Update for Nurses on Novel Treatment and Management of ITP

Ramaswamy Govindan, MD; Piro Lito, MD, PhD

Expert Illustrations & Commentaries™: Harnessing the Power of KRAS Inhibition to Treat Solid Tumors

Colin W. Howden, MD, FRCP (Glasg.), FACP, AGAF, FACG, FCP

Advances In™ Overcoming Barriers to Diagnosis and Treatment of Helicobacter pylori Infections

Jose Javier Provencio, MD; Jennifer Frontera, MD: Edward Manno, MD, MS

Understanding Best Care Practices for Hemorrhagic Stroke: A Focus on the Role of DOAC Reversals

Locally Advanced and Metastatic Bladder Cancer: Transforming the Treatment Paradigm

New and Emerging Oral Oncolytics and the Role of the Oncology Team in Optimizing Patient Outcomes

Oncology Biosimilars: Educating the Oncology Health Care Team to Facilitate Implementation Into Clinical Practice

Stephen A. Brunton, MD, FAAFP, CDCES; Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASH; James A. Underberg, MD, MS, FACPM, FACP, FNLA, FASPC; Kim Zuber, PA-C

Community Practice Connections™: The 5th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Arjun V. Balar, MD; Robert Dreicer, MD, MS, MACP, FASCO; Sima Porten, MD, MPH, FACS; Scott T. Tagawa, MD, MS, FACP

Medical Crossfire®:  How Should We Leverage Immunotherapeutic and Targeted Strategies Across Lines of Care in Bladder Cancer?

Exploring Emerging Immunotherapies in Melanoma

Naval G. Daver, MD; Claudio Cerchione, MD, PhD; Elias Jabbour, MD; Hagop M. Kantarjian, MD;Giovanni Martinelli, MD

Medical Crossfire®: Practical Considerations for Integrations of Biosimilars Into Patient Care Pathways for Hematologic Malignancies

Gail J. Roboz, M.D., Naval G. Daver, MD, Amir T. Fathi, MD

2021 SOHO ISS: Medical Crossfire®: How Can We Leverage Emerging Data to Optimize Outcomes Across Lines of Care in AML?

Stephen Brunton, MD, FAAFP; George Bakris, MD; Eden Miller, DO; Jay H. Shubrook, DO, FACOFP, FAAFP

A Family Physician's Guide to Chronic Kidney Disease: Evolving Strategies and Emerging Data

Oncology Consultations®: Challenging the Experts on How They Treat and Individualize Care in NSCLC with ALK Inhibitors

Danielle Roman, PharmD, BCOP; Allison Schepers, PharmD, BCOP; Laura R. Bobolts, PharmD, BCOP

Triple-Negative Breast Cancer: Perspectives on the Disparities in Care and Managed Care Considerations for the Advancing Treatment Paradigm

Grace Cherry, MSN, RN, NP; Beth Sandy, MSN, CRNP; Laura S. Wood, MSN, OCN

Community Practice Connections™: 5th Annual School of Nursing Oncology™

John P. Bilezikian, MD, PhD; Robin Cornell Creamer, DO, FAAFP; E. Michael Lewiecki, MD, FACP, FACE

Opportunities to Strengthen Osteoporosis Treatment and Prevention Practices in Primary Care

Expert Illustrations & Commentaries: Exploring the Rationale and Application of XPO1 Inhibitors in Hematologic Malignancies

Oncology Briefings™: Navigating Novel Emerging Chemotherapeutic Regimens for Patients with ALL

Philippe Armand, MD, PhD; Loretta J. Nastoupil, MD; Jason Westin, MD, MS, FACP

Community Practice Connections™: Medical Crossfire®: How Are We Integrating New Treatment Strategies Into the Care of Our B-Cell Lymphoma Patients?

David R. Gandara, MD; Marina Garassino, MD; Roy S. Herbst, MD, PhD; Heather A. Wakelee, MD

Community Practice Connections™: 22nd Annual International Lung Cancer Congress®

Seth J. Baum, MD, FACC, FAHA, FACPM, FNLA, FASPC; Pam R. Taub, MD

Protecting Our Patients From ASCVD: Optimizing the Use of Non-Statin Therapies

Giada Bianchi, MD, Matthew Ho, MB BCh, BAO, PhD

Clinical ShowCase™: Applying the Evidence to Case Scenarios in Relapsed/Refractory Multiple Myeloma

Christoph U Correll, MD; Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Advances in™ Bipolar Depression: Expert Strategies to Optimize Patient Outcomes in Depressive Episodes

Colleen A. McEvoy, MD; Colleen A. McEvoy, MD

Clinical Consultations™: Finding Opportunities to Improve the Management of Patients with Connective Tissue Disease-associated Pulmonary Arterial Hypertension (CTD-PAH)

Michael E. Wechsler, MD, MMSc; Praveen Akuthota, MD; Anna Kovalszki, MD

“D” is for Diagnosis® - Cracking the Case in Rare Disorders with Respiratory Symptoms: Practical Approaches to Identification and Clinical Management

Guillermo Garcia-Manero, MD; Kelly S. Chien, MD; Rami S. Komrokji, MD

Personalizing Care for Patients With Low- to High-Risk MDS: Applying the Science to Real-World Case Scenarios

Anita Clayton, MD; John J. Miller, MD; Sanjai Rao, MD

2021 Annual Psychiatric Times™ World CME Conference™ - Day Two

2021 Annual Psychiatric Times™ World CME Conference™ - Day One

2021 Annual Psychiatric Times™ World CME Conference™ - Day Three

Oncology Briefings™: Update for Nurses on Novel Treatment and Management Approaches in Melanoma

Advances In™: The Role of NRG1 Fusions Across Tumor Types

Cancer Summaries and Commentaries®: Updates From Chicago on the Treatment of Lung Cancer

Amy E. DeZern, MD, MHS; Mikkael Sekeres, MD, MS

Expert Illustrations & Commentaries™: Reshaping the Clinical Landscape of HR-MDS Through Novel Mechanisms of Action

Aditya Bardia, MD, MPH; Sara A. Hurvitz, MD; 

Advances In™ Breast Cancer: New Frontiers in the Management of ER+ Disease

Oliver Sartor, MD; Tomasz M. Beer, MD, FACP; Alicia K. Morgans, MD, MPH; Fred Saad, MD, FRCS, FCAHS

Medical Crossfire®: Individualizing Treatment in CRPC Based on Patient and Disease-Specific Factors

Cristina Saura, MD, PhD; Yelena Y. Janjigian, MD; Maurice Prol, MD

Medical Crossfire®: How the Experts Approach Testing and Treatment When Utilizing PARP Inhibitors for mCRPC

Expert Illustrations & Commentaries™: Iron Deficiency in Patients With Chronic Kidney Disease – An Inside Look at Pathogenesis and Evidence-Based Management

Narcolepsy In the Advanced Practice Setting—Utilizing Evidence-Based Care to Improve Patient Outcomes

“Off-the-Shelf” Allogeneic CAR T Cells

Advances In™: The Evolving Role of Antibody-Drug Conjugates for Treatment of TNBC

Daniel J. DeAngelo, MD, PhD; Bijal D. Shah, MD, MS

Cancer Summaries and Commentaries®: Updates from the Summer Meetings on the Treatment of Acute Lymphoblastic Leukemia

Patient, Provider, and Caregiver Connection™: Collaborative Approaches to Chronic Kidney Disease Management in T2DM

Richard Channick, MD; Vallerie McLaughlin, MD

Advances In™ PAH Associated with Congenital Heart Disease (PAH-CHD): Designing New Treatment Strategies Backed by Better Disease Understanding

Sara Hurvitz, MD, FACP; William J. Gradishar, MD, FASCO, FACP;  Joyce O’Shaughnessy, MD; Debu Tripathy, MD

Community Practice Connections™: 20th Annual International Congress on the Future of Breast Cancer®

George Bakris, MD; Jon W. Mares, DO; Biff F. Palmer, MD; Ileana L Piña, MD, MPH, FAHA, FACC, FHFSA

Virtual Case Studies™ in Chronic Kidney Disease: Optimizing Patient Selection When Considering Non-Steroidal Mineralocorticoid Receptor Antagonists

Ronald Hoffman, MD; Kathryn Johnson, DNP, MSc, FNP-BC; Marina Kremyanskaya MD, PhD; Naveen Pemmaraju, MD

3rd Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

Medical Crossfire®: How Are We Meeting the Needs of Patients With CLL Across Lines of Care?

Medical Crossfire®: How Are We Integrating New Treatment Strategies Into the Care of Our B-Cell Lymphoma Patients?

Andre Goy, MD; Samuel A. Goldlust, MD; Nicholas J. DeNunzio, MD, PhD; George J. Kaptain, MD, FAANS; James L. Rubenstein, MD, PhD

Mentors in Medicine Series on Applied Precision Medicine: Focus on Treating CNS Tumors and Metastases

Sagar Lonial, MD, FACP; Jennifer Zreloff, MD

Oncology Briefings™: Coordinating the Long-Term Management of Patients with Multiple Myeloma Between Primary Care and Oncology Practice

Community Practice Connections™: Harmonizing Clinical Practices: Strategies for Rapid Diagnosis and Acute Management of Acquired TTP

Hope S. Rugo, MD, FASCO; Sara M. Tolaney, MD, MPH

Oncology Consultations®: The Evolving Treatment Landscape for Triple-Negative Breast Cancer: What Clinicians Need to Know

Rami Komrokji, MD; Amer Zeidan, MBBS, MHS

Reflective Case-Based Oncology Collective™: Translating Recent Evidence to the Real-World Management of Myelodysplastic Syndromes

Elias Jabbour, MD; Jae Park, MD; Jerald P. Radich, MD

How Can We Be More Strategic in Treatment Planning for Patients with ALL?

Saad Z. Usmani, MD, MBA, FACP; Surbhi Sidana, MD; Carlyn R. Tan, MD 

Managing Multiple Myeloma From Newly Diagnosed to Relapsed/Refractory Settings: An Expert Case-Based Discussion

Elias Jabbour, MD; Hagop M. Kantarjian, MD; Shilpa Paul, PharmD, BCOP

Navigating Treatment Options for CML Across the Disease Continuum: An Expert Case-Based Discussion

Mikkael A. Sekeres, MD; Amy DeZern, MD, MHS; Rami S. Komrokji, MD; Bhumika Patel, MD

Community Practice Connections™: Exploring Current and Emerging Data Sets to Move Treatment of Higher-Risk MDS Forward: A Focus on Novel Targets and Treatment Approaches

Balazs Halmos, MD, MS; Lynette M. Sholl, MD; Yelena Y. Janjigian, MD

Community Practice Connections™: 5th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards

Peter Martin, MD; Jonathon B. Cohen, Md MS; Kami Maddocks, MD; Elizabeth Budde, MD, PhD

Medical Crossfire®: How are the Experts Applying the Latest Advances for Patients with Mantle Cell Lymphoma?

Oncology Briefings™: Optimizing Care in Oncogene-Driven Advanced NSCLC

Rita R. Alloway, PharmD; Daniel Brennan, MD; E. Steve Woodle, MD, FACS

Community Practice Connections™: Let's Get “Real”: Minimizing Allograft Rejection in Renal Transplantation – Applying the Evidence to Real-World Scenarios

Kevin Winthrop, MD, MPH; David E. Griffith, MD

Patient, Provider, & Caregiver Connection™: Patient Perspectives in Non-Tuberculous Mycobacteria Lung Disease

James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA

Continuing Medical Education